Amanda Ingham Adler trained in economics, medicine and epidemiology. She chairs a multi-disciplinary Technology Appraisal Committee at the National Institute for Health Excellence (NICE) and is a consultant physician at Addenbrooke’s Hospital, Cambridge. Her clinical work involves patients in-hospital, in out-patient clinics, and in the community. She holds an honorary position with the MRC Epidemiology Unit, Institute of Metabolic Sciences, Cambridge University.
Previous roles include Clinical Epidemiologist, UK Prospective Diabetes Study, Oxford University and Chair, NICE guideline committee addressing Newer Agents for Blood Glucose Control in Type 2 Diabetes. Dr. Adler has advised the European Medicines Agency and the UK Medicines and Healthcare products Regulatory Agency (MHRA). With the World Bank, she has provided technical assistance to Bulgaria, the Maldives, and India. She has participated in projects with the UK Department for International Development, NICE International, the Gates Foundation, the World Health Organization (WHO), and the Organisation for Economic Co-operation and Development (OECD).